Single Blind, Randomized Control Study is designed to evaluate the tolerability of the Celero Systems' modified Health-Dx™ (mHDx) capsule.

Inclusion Criteria:

• Healthy individuals ages 18 - 75 inclusive
• Subject is a suitable candidate for study participation in the opinion of the Investigator
• Subject has been informed of the nature of the study and has provided written informed consent as approved by the WVU IRB

Exclusion Criteria:

• Subjects with a history of any condition that may impact the GI tract
• Subjects who are unable to swallow a 000 sized capsule
• Subjects with an implanted medical device that has wireless data communication capability
• Subjects planning to undergo an MRI within 30 days after the study
• Subjects with a BMI > 40 (severe obesity)
• Subjects who are pregnant or are nursing
• Any subject deemed to be at risk of a gastrointestinal complication as evaluated by a gastroenterologist prior to study enrollment